Antiviral nasal drop maker does the Nasdaq shuffle as part of minor SPAC reverse merger

Revelation Biosciences, a San Diego biotech working on antiviral nasal drops, will go public as part of a reverse merger with the Petra Acquisitions SPAC announced Tuesday.